This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Acucela Inc.. Active years: 2023-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2024
Title: Jacobus Antonius Joseph Den Hartog: Innovator in VAP-1 Modulation
Introduction
Jacobus Antonius Joseph Den Hartog is a notable inventor based in Weesp, Netherlands. He has made significant contributions to the field of pharmaceutical innovations, particularly in the modulation of VAP-1 activity. With a total of 3 patents to his name, Den Hartog continues to push the boundaries of scientific research and development.
Latest Patents
Den Hartog's latest patents focus on inhibitors of VAP-1. These patents provide compounds and methods for the modulation of VAP-1 activity, showcasing his commitment to advancing medical science. The innovative approaches outlined in these patents have the potential to impact therapeutic strategies significantly.
Career Highlights
Den Hartog is currently associated with Acucela Inc., where he applies his expertise in developing novel therapeutic solutions. His work at Acucela Inc. reflects his dedication to improving healthcare outcomes through innovative research.
Collaborations
Throughout his career, Den Hartog has collaborated with esteemed colleagues, including Mark W Orme and Edison S Zuniga. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.
Conclusion
Jacobus Antonius Joseph Den Hartog is a distinguished inventor whose work in VAP-1 modulation exemplifies the spirit of innovation in the pharmaceutical industry. His contributions continue to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile